Tropomodulins are novel regulators of actomyosin crossbridge formation and muscle contractility in skeletal muscle.
Tmod1 supports skeletal muscle contractility in rodents; leaves open relevance to human muscle function or therapeutic targeting.
In skeletal muscle, thick and thin filaments are arranged in a myofibrillar lattice. Tropomodulin 1 (Tmod1) is a pointed‐end capping and tropomyosin‐binding protein that controls thin‐filament assembly, stability, and lengths. It remains unknown whether Tmods have other functional roles, such as regulating muscle contractility. To investigate this, we recorded and analyzed the mechanical properties and X‐ray diffraction patterns of single membrane‐permeabilized skeletal muscle fibers from mice lacking Tmod1. Results show that absence of Tmod1 and its replacement by Tmod3 and Tmod4 may impair initial tropomyosin movement over actin subunits during thin‐filament activation, thus reducing both the fraction of actomyosin crossbridges in the strongly bound state (–29%) and fiber force‐generating capacity (–31%). Therefore, Tmods are novel regulators of actomyosin crossbridge formation and muscle contractility, and future investigations and models of skeletal muscle force production must incorporate Tmods.—Ochala, J., Gokhin, D. S., Iwamoto, H., Fowler, V. M. Pointed‐end capping by tropomodulin modulates actomyosin crossbridge formation in skeletal muscle fibers. FASEB J . 28, 408–415 (2014). www.fasebj.org
No takes yet. Share an insight, caveat, or question.
Ochala et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: